Collplant Biotechnologies LTCLGN
13F holders, Q2 2024 (June 30)15holders +3
4new positions
1sold out
$4.97avg. 13F price*
At the end of Q2 2024, 15 institutions reported holding Collplant Biotechnologies LT (CLGN) in their 13F filings, up 3 from Q1 2024. 4 opened new positions and 1 sold out. The largest holders were Pinnacle Associates Ltd. ($2.8M), Villere St Denis J & Co. LLC ($1.9M) and Roumell Asset Management, LLC ($1.4M).
- Company
- Collplant Biotechnologies LT
- CUSIP
- M2R51X116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $383K |
| Exits | 1 | $71K |
All 13F filers, Q1 2024 → Q2 2024: 136,325 shares bought and 62,812 shares sold, net +73,513 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Pinnacle Associates Ltd. | 0.04% | Add +6.4% | 564,360 | $2.8M |
| Villere St Denis J & Co. LLC | 0.17% | Add +6.2% | 389,867 | $1.9M |
| Roumell Asset Management, LLC | 2.57% | Reduce -12.3% | 276,430 | $1.4M |
| Brown Advisory Inc. | 0.00% | Reduce -0.1% | 119,465 | $594K |
| AMH Equity Ltd | 0.56% | New | 75,647 | $376K |
| Benjamin F. Edwards & Company, Inc. | 0.00% | Reduce -21.2% | 39,760 | $197K |
| Bank of America Corp. | 0.00% | No change | 7,300 | $36K |
| UBS Group AG | 0.00% | Add +49.4% | 7,142 | $35K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 3,600 | $18K |
| Redwood Wealth Management Group, LLC | 0.00% | New | 1,310 | $7K |
| National Bank of Canada | 0.00% | No change | 250 | $1K |
| Osaic Holdings, Inc. | 0.00% | New | 200 | $994 |
| Qube Research & Technologies Ltd | 0.00% | No change | 6 | $30 |
| Morgan Stanley | 0.00% | No change | 1 | $8 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1 | $5 |
"% of holder's portfolio" is CLGN's weight in each manager's 13F, not the share of Collplant Biotechnologies LT the manager owns.